Back to ARQT
D. E. Shaw & Co., Inc. ARQT Position History
Arcutis Biotherapeutics, Inc. • Healthcare
Quarters held
21
Latest value
$22.3M
Q2 2026
Peak value
$81.2M
First seen
Q3 2022
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2022 | $1.4M |
| Q4 2022 | $550K |
| Q1 2024 | $2M |
| Q1 2024 | $164K |
| Q2 2024 | $9.4M |
| Q3 2024 | $16.1M |
| Q3 2024 | $116K |
| Q4 2024 | $33.6M |
| Q4 2024 | $1.4M |
| Q1 2025 | $27.2M |
| Q1 2025 | $4M |
| Q2 2025 | $25.6M |
| Q2 2025 | $4.7M |
| Q3 2025 | $28.1M |
| Q3 2025 | $11.9M |
| Q4 2025 | $58.5M |
| Q4 2025 | $19.4M |
| Q1 2026 | $44.3M |
| Q1 2026 | $14.5M |
| Q2 2026 | $81.2M |
| Q2 2026 | $22.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $22.3M | 852.0K | — | — |
| Q2 2026 | $81.2M | 3.10M | — | — |
| Q1 2026 | $14.5M | 614.4K | — | — |
| Q1 2026 | $44.3M | 1.88M | — | — |
| Q4 2025 | $19.4M | 668.5K | — | — |
| Q4 2025 | $58.5M | 2.01M | — | — |
| Q3 2025 | $11.9M | 629.1K | — | — |
| Q3 2025 | $28.1M | 1.49M | — | — |
| Q2 2025 | $4.7M | 337.1K | — | — |
| Q2 2025 | $25.6M | 1.83M | — | — |
| Q1 2025 | $4M | 253.0K | — | — |
| Q1 2025 | $27.2M | 1.74M | — | — |
| Q4 2024 | $1.4M | 98.2K | — | — |
| Q4 2024 | $33.6M | 2.42M | — | — |
| Q3 2024 | $116K | 12.5K | — | — |
| Q3 2024 | $16.1M | 1.73M | — | — |
| Q2 2024 | $9.4M | 1.01M | — | — |
| Q1 2024 | $164K | 16.5K | — | — |
| Q1 2024 | $2M | 200.4K | — | — |
| Q4 2022 | $550K | 37.2K | — | — |
| Q3 2022 | $1.4M | 74.4K | — | — |
Other funds holding ARQT
$152.7M
$152.7M
$148.3M
$109M
$104M
$90.1M
$65.7M